Home About
BD&L Summit · Munich · November 2026

About the
BD&L Summit

The BioPharma Deals Conference was built from the ground up to serve the discipline of Business Development & Licensing in life sciences — with the depth, rigour, and deal focus it has always deserved.

BD&L Leaders
Expert Speakers
Countries
Senior Level Attendance
Life sciences conference dealmakers
2026 Munich, Germany
Our Mission

Built for the
Dealmakers of Medicine

“To create the definitive global gathering for life sciences BD&L professionals where strategic deals get done, critical market intelligence is exchanged, and high value partnership that advances asset development and innovation takes shape.”

The BioPharma Deals Conference exists because the discipline of Business Development & Licensing deserves its own dedicated forum — not a track at a general pharma congress, but a full summit engineered around the realities, challenges, and opportunities facing today's dealmaking.

We bring together the most active BD&L professionals in the industry — licensing directors, Chief BD Officers, biotech founders, life sciences investors, and M&A advisors — in a high-intensity two-day format designed to generate real commercial outcomes.

Licensing M&A Co-Development Partnering Capital Raising IP Strategy
Our Journey

How We Built
Europe's BD&L Epicentre

The BioPharma Deals Conference was created by life sciences BD&L practitioners who understood precisely what was missing from the European conference landscape.

The Insight
A Gap in the Market — and in the Industry

After years attending general pharma and biotech conferences, our founders identified a persistent absence: there was no dedicated, senior-level summit built exclusively around the mechanics and strategy of BD&L. Every existing event treated it as a side conversation. We decided to make it the only conversation.

01
The Build
Designing Every Element for Deal Outcomes

We spent 18 months interviewing Chief BD Officers, licensing directors, and M&A advisors across Europe and the US. Every format decision — from the structure of partnering sessions to the curation of the speaker faculty — was made with one question in mind: does this generate real deal momentum?

02
The Launch
BioPharma Deals Opens Its Doors in Munich

We chose Munich deliberately — the heart of Europe's most dynamic life sciences cluster, home to a thriving community of pharma, biotech, and investor organisations with the connectivity and culture to host a genuinely international BD&L gathering. The response from the industry was immediate.

03
The Summit — 2026
The BD&L Event the Industry Has Been Waiting For

The 2026 edition brings together 200+ of Europe's and the world's most active BD&L professionals for two intensive days of deal intelligence, facilitated partnering, expert panels, and senior networking — all engineered around the one goal that matters: helping you close your next deal.

04
What We Stand For

Four Principles That
Define Everything We Do

01
Deal Focus, Always

Every session, every format, every facilitated interaction is designed around a single outcome: helping attendees initiate, advance, or close a business development deal. We eliminate everything that doesn't serve that goal.

02
Rigorous Curation

We review every registration manually. The result is a room where 85% of attendees hold VP-level or above titles and every person present has the authority and genuine intent to initiate a deal. Quality of audience over quantity of tickets.

03
Practitioner Intelligence

Our speakers are active dealmakers — Chief BD Officers, General Counsels, fund managers, and licensing veterans who are closing transactions today. No theorists, no academics. Real intelligence from people in the arena.

04
Measurable Outcomes

We measure our success by yours. Attendees have reported initiating term sheets, signing NDAs, and advancing investment conversations directly from meetings made here. We don't consider a summit successful unless deals move forward.

Munich conference venue Munich city view
The Venue

Munich —
Europe's Life Sciences Capital

Munich is not an accidental choice. It sits at the centre of Europe's most dynamic life sciences corridor — with direct connectivity to pharma hubs in Switzerland, Nordics, and the UK, and a thriving local ecosystem of biotech, medtech, and investor organisations.

Our venue provides a purpose-designed environment for dealmaking: a main auditorium for keynotes and panels, dedicated rooms for 1:1 partnering sessions, breakout spaces for workshops, and premium networking and dining facilities for the evening programme.

Central Location

Munich city centre, 40 min from Munich Airport (MUC)

Two Full Days

24–25 November 2026 — full catering included

Capacity

Maximum 300 delegates — intentionally intimate

Connectivity

Direct flights from 200+ cities. Hotel room blocks available.

Supporting Organisations

Past & Supporting Organisations

Professionals from these organisations have attended, spoken, and partnered at BioPharma Deals

DBT MassBio AFSSI InvestHK Euronext Danish Biotech California Life Sciences ASEBIO North Carolina Biotech BIOM Nordic Life Science NC Life Sciences South Dakota Biotech Swiss Biotech Association BioCon Valley Pharma Partnering Summit Conference in Europe International Conference Alert Conference Next All Conference Alert PR Gateway Medical Tech Outlook APAC CIO Applications Europe Hospitals Management PharmaShots Everything Radiography Proplanta Agrar Presseportal GxP News Healthcare Business Review APAC Energy Tech Review APAC International Biopharmaceutical Industry
FAQ

Frequently Asked
Questions

Everything you need to know about attending, partnering, networking, and maximizing your return on investment at the BioPharma Deals – BD&L Summit.

Contact Us
The BD&L Summit is designed for senior decision-makers responsible for driving growth, partnerships, and innovation across the global life sciences ecosystem. Attendees typically include Chief Business Officers, Heads of Business Development & Licensing, Corporate Strategy Leaders, Alliance Management Executives, Biotech and Pharma CEOs, Venture Capital Investors, Corporate Venture Teams, M&A Professionals, and R&D Leaders actively seeking licensing opportunities, strategic partnerships, investments, and transformative collaborations.
BD&L Summit brings together senior executives from pharmaceutical companies, biotechnology firms, venture capital organizations, investment groups, academic institutions, technology providers, CROs, CDMOs, and life sciences service organizations.
The summit is expected to welcome more than 200 senior-level delegates from across the global life sciences ecosystem, creating a highly focused environment for networking, knowledge exchange, and business development.
The majority of attendees are senior decision-makers, including C-suite executives, Vice Presidents, Directors, Heads of Business Development, Licensing Leaders, Founders, Investors, and Corporate Strategy professionals with responsibility for evaluating and executing partnerships and transactions.
Yes. All registered delegates will receive access to the official partnering platform three weeks prior to the event. The platform will contain attendee profiles, company information, partnering interests, and meeting request functionality. Delegates can review profiles, identify potential partners, and schedule one-to-one meetings in advance, ensuring a productive and highly targeted networking experience in Munich.
The summit will take place at the Science Congress Center Munich, Germany. Located in one of Europe's leading innovation and biotechnology hubs, the venue provides an exceptional environment for strategic networking, business discussions, and high-level partnering meetings.
Unlike traditional conferences, BioPharma Deals is purpose-built for partnership creation and business growth. By combining expert-led discussions, curated networking, investor engagement, and pre-arranged one-to-one meetings, the summit creates a focused environment where meaningful conversations can lead to real licensing deals, collaborations, investments, and strategic partnerships.
Munich · 24–25 November 2026

Your Next Deal
Starts Here

Join Europe's most focused gathering of BD&L professionals. Two days. Three hundred dealmakers. One shared ambition: to close the deals that advance the science of life.

Register Now Contact the Team